Mark Thomas and Stephen Ritchie explain how dramatically reducing antibiotic use for upper respiratory tract infections can make life better for patients, and for the health system
Many pharmacists believe the upcoming reduction in funding for providing COVID-19 antivirals makes the service financially unviable, and some say they may refuse to offer it as a result
The Government has confirmed that a second phase of the Royal Commission of Inquiry into COVID-19 Lessons Learned will begin in November with new commissioners and expanded terms of reference
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes